the members of the Joslin Clinical Oversight Committee
Articles
June 23rd 2018
CHAPTER 5. Clinical Guideline for Pharmacological Management of Adults With Type 2 Diabetes
Om P. Ganda, MD, Chair, Clinical Oversight Committee Alissa Segal, PharmD, CDE, CDTC Elizabeth Blair, MS, ANP-BC, CDE, CDTC Richard Beaser, MD Jason Gaglia, MD Elizabeth Halprin, MD Robert A. Gabbay, MD, PhD, FACP the members of the Joslin Clinical Oversight Committee
From the Adult Diabetes and Clinical Research Sections, Joslin Diabetes Center, Harvard Medical School. Approved May 10, 2016; updated April 24, 2018. For the Figure and Tables, download the PDF at the end of the chapter.
June 23rd 2018
Osama Hamdy, MD, PhD Om P. Ganda, MD, Chair, Clinical Oversight Committee Melinda Maryniuk, MEd, RD, CDE Robert A. Gabbay, MD, PhD, FACP the members of the Joslin Clinical Oversight Committee
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
June 22nd 2018
CHAPTER 1. Clinical Guideline for Adults With Diabetes
Samar Hafida, MD Om P. Ganda, MD, Chair, Clinical Oversight Committee Robert A. Gabbay, MD, PhD, FACP the members of the Joslin Clinical Oversight Committee
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 1st 2024 | Updated: November 21st 2024
Table Multiple Myeloma Trials November 2024
